Celebration of Innovation 2021 Recap and Recording
The event honors the patent recipients from the previous fiscal year, as well as, those partners, inventors, and startups that made exceptional achievements.
This tech startup is helping N. Philadelphians take control of their health
The founder, Deboleena (Deb) Dutta graduated from Wharton and participated in the PCI I-Corps program with Viora Health.
I-Corps graduate, Strella Biotechnology, featured in Washington Post story
A featured story on Katherine Sizov, founder of Strella Biotechnology, and how the company's sensors are reducing food waste and fighting climate change.
Webinar Recording: Pennovation Works Resources
During this PCI webinar, Anish Kumar, the Managing Director of the Pennovation Works campus, discusses the past and future of Pennovation Works.
Webinar Recording: VC 101 for University Entrepreneurs
PCI hosted a webinar with Kirsten Leute and Margalit Haber of Osage University Partners on venture capital and investing for university entrepreneurs in the life science field
Celebrating five years of innovation, entrepreneurship, and creativity
Penn Today marks the anniversary of Pennovation Works with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
After setbacks, cell therapy for glioblastoma moves onto new chapter
At Penn, a leader in GBM cellular therapies since the early days of this technology, a new CAR cell therapy could find its way into clinical trials by next year in collaboration with Tmunity.
NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases
NIH, FDA, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for rare diseases.
Webinar Recording: Penn at the B.PHL
The session, titled Feminine Energy: Female Founders Solving Sustainability Challenges, was a panel format featuring a Penn spinout, Pennovation tenants, and a Penn partner.
Scout Bio raises $4.75M to advance gene therapy for pets
The company has now raised more than $35 million since its inception.